Population
Patients with Brugada syndrome characterized by idiopathic polymorphic ventricular tachycardia or…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Standardizes ECG diagnosis and ICD use in Brugada syndrome; leaves open prospective validation of refined risk stratification.
Key Points
- To delineate the clinical presentation, electrophysiological mechanisms, genetic basis, and diagnostic criteria of Brugada syndrome.
- Synthesized clinical and electrocardiographic data from patients presenting with idiopathic polymorphic ventricular arrhythmias and sudden cardiac arrest.
- Evaluated electrophysiological repolarization disparities across ventricular myocardial layers and documented associated cardiac sodium channel mutations.
- Brugada syndrome manifests as ST-segment elevation across leads V1 through V3 with right bundle branch block without detectable structural heart disease, ischemia, or electrolyte imbalance.
- Arrhythmic events, including syncope and ventricular fibrillation, occur predominantly in males during sleep or rest due to epicardial-to-endocardial repolarization dispersion linked to SCN5A missense mutations.
- Patient prognosis remains poor without an implantable cardioverter defibrillator, necessitating careful exclusion of structural diseases such as arrhythmogenic right ventricular cardiomyopathy.
Structured PICO
P
Population
Patients with Brugada syndrome characterized by idiopathic polymorphic ventricular tachycardia or ventricular fibrillation, right bundle branch block, and ST-segment elevation from V1 to V2-V3, predominantly affecting males.
Brugada syndrome is a genetic arrhythmogenic disorder characterized by a specific ECG pattern and high risk of sudden cardiac death, requiring careful diagnosis and ICD implantation for prevention.
Cite This Study
Corrado et al. (1999) studied this question.